These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2885172)

  • 1. [Clinical pharmacokinetics of haloperidol decanoate. Comparison with other prolonged-action neuroleptics].
    Levron JC; Ropert R
    Encephale; 1987; 13(2):83-7. PubMed ID: 2885172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of the depot antipsychotics.
    Jann MW; Ereshefsky L; Saklad SR
    Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
    Knudsen P
    Acta Psychiatr Scand Suppl; 1985; 322():51-75. PubMed ID: 2866666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
    Turner M; Eerdekens E; Jacko M; Eerdekens M
    Int Clin Psychopharmacol; 2004 Jul; 19(4):241-9. PubMed ID: 15201572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
    Kissling W; Möller HJ; Walter K; Wittmann B; Krueger R; Trenk D
    Pharmacopsychiatry; 1985 May; 18(3):240-5. PubMed ID: 4011672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs.
    Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
    J Pharm Sci; 1976 Apr; 65(4):502-507. PubMed ID: 1271246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.
    Gelders YG
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-11. PubMed ID: 3559159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
    Jrgensen A; Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():41-54. PubMed ID: 6931472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
    Viala A; Ba B; Durand A; Gouezo F; Hou N; Jørgensen A
    Psychopharmacology (Berl); 1988; 94(3):293-7. PubMed ID: 2895936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats.
    Richardson NR; Smith AM; Roberts DC
    Drug Alcohol Depend; 1994 Aug; 36(1):23-5. PubMed ID: 7988355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of long-acting antipsychotic medications.
    Spanarello S; La Ferla T
    Curr Clin Pharmacol; 2014; 9(3):310-7. PubMed ID: 23343447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
    Wiles DH; McCreadie RG; Whitehead A
    Psychopharmacology (Berl); 1990; 101(2):274-81. PubMed ID: 2349370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
    Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.